The drugs, from a class of digestion-slowing medicines known as GLP-1 agonists, have eaten into demand at some big companies, ...

We recently published a list of the Best Income Stocks to Invest in Now. In this article, we are going to take a look at ...

The request follows a similar move by Eli Lilly, which has asked for a ban on other parties making copies of its tirzepatide-based therapies Mounjaro for diabetes and Zepbound for obesity ...